Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun:179:106109.
doi: 10.1016/j.micpath.2023.106109. Epub 2023 Apr 9.

Integrated immune monitoring of HCMV infection in pregnant women with complications and its association with adverse pregnancy outcomes

Affiliations

Integrated immune monitoring of HCMV infection in pregnant women with complications and its association with adverse pregnancy outcomes

Harsha Chandrashekhar Palav et al. Microb Pathog. 2023 Jun.

Abstract

Human Cytomegalovirus (HCMV) infection is associated with bad obstetric history (BOH) and adverse pregnancy outcomes (APO). Here, we characterized antiviral humoral profiles, systemic and virus specific cellular immune responses concurrently in pregnant women (n = 67) with complications including BOH and associated these signatures with pregnancy outcomes. Infection status was determined using nested blood PCR, seropositivity and IgG avidity by ELISA. Systemic and HCMV specific (pp65) cellular immune responses were evaluated by flow cytometry. Seropositivity was determined for other TORCH pathogens (n = 33) on samples with recorded pregnancy outcomes. This approach was more sensitive in detecting HCMV infection. Blood PCR positive participants, irrespective of their IgG avidity status, had higher cytotoxic potential in circulating CD8+ T cells (p < 0.05) suggesting that infection associated cellular dysfunction was uncoupled with avidity maturation of antiviral humoral responses. Also, impaired anamnestic degranulation of HCMV-pp65-specific T cells compared to HCMV blood PCR negative participants (p < 0.05) was observed. APO correlated with HCMV blood PCR positivity but not serostatus (p = 0.0039). Most HCMV IgM positive participants (5/6) were HCMV blood PCR positive with APO. None were found to be IgM positive for other TORCH pathogens. Multiple TORCH seropositivity however was significantly enriched in the APO group (p = 0.024). Generation of HCMV specific high avidity IgG antibodies had no bearing on APO (p = 0.9999). Our study highlights the utility of an integrated screening approach for antenatal HCMV infection in the context of BOH, where infection is associated with systemic and virus specific cellular immune dysfunction as well as APO.

Keywords: Adverse pregnancy outcomes; Bad obstetric history; HCMV infection; IgG avidity; PCR.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Obstetric history of pregnant women with (A) pregnancy complications in primigravida (PC) and (B) Bad Obstetric History (BOH). N = Number of participants in which the complication was seen. SA: spontaneous abortion; IUFD: intrauterine fetal death; MA: missed abortion; FGR: fetal growth restriction.
Fig. 2
Fig. 2. Distribution of HCMV seropositivity in pregnant women with BOH and PC.
(A) HCMV Serology status; n = 67 (B) HCMV IgG Avidity status; n = 59 (C) HCMV infection status; n = 59. +: Positive; -: Negative.
Fig. 3
Fig. 3. Cytotoxic potential in PN (n = 14) and PP (n = 35) pregnant women with BOH and PC.
(A) % Granzyme-B expressing T cells (CD3+) (B) % Granzyme-B expressing CD8+ T cells (C) % Granzyme-B expressing CD4+ T cells Data points in red indicates samples for which ICCS Assay was performed. Comparisons between groups were evaluated by non-parametric Mann–Whitney U test (*p < 0.05; **p < 0.01; nsp ≥0.05). p < 0.05 was considered significant.
Fig. 4
Fig. 4. Phenotypic and functional systemic immune response during second trimester in PN (n = 9) and PP (n = 15) pregnant women with BOH and PC.
(A) % Granzyme-B expressing T cells (CD3+) (B) % Granzyme-B expressing CD8+ T cells (C) % CD4+ T cells (D) % CD8+ T cells (E) CD4/CD8 Ratio. Data points in red indicates samples for which ICCS Assay was performed. Comparisons between groups were evaluated by non-parametric Mann–Whitney U test (*p < 0.05; **p < 0.01; nsp ≥0.05). p < 0.05 was considered significant.
Fig. 5
Fig. 5. HCMV specific immune response in PN (n = 7) and PP (n = 6) pregnant women with BOH and PC.
(A) % CD107a expressing monofunctional CD4+ and CD8+ T cells. Data points in green indicates samples for which pregnancy outcome was available (B) Comparison of % CD107a expressing monofunctional CD4+ and CD8+ T cells between unstimulated (UN) and positive control (PMA) in PN and PP group. (C) CD107a expressing different monofunctional T cell subsets; TCM: Central Memory, TN: Naive, TEM: Effector Memory, TTD: Terminally differentiated in unstimulated and stimulated condition (pp65 peptide pool). Comparisons between groups were evaluated by non-parametric Mann–Whitney U test (*p < 0.05; nsp ≥0.05). p < 0.05 was considered significant.

Similar articles

Cited by

References

    1. Picarda G, Benedict CA. Cytomegalovirus: shape-shifting the immune system. J Immunol. 2018;200:3881–3889. doi: 10.4049/jimmunol.1800171. - DOI - PMC - PubMed
    1. Kourí V, Correa CB, Verdasquera D, Martínez PA, Alvarez A, Aleman Y, Perez L, Golpe MA, Someilán T, Chong Y, Fresno C, et al. Diagnosis and screening for cytomegalovirus infection in pregnant women in Cuba as prognostic markers of congenital infection in newborns: 2007-2008. Pediatr Infect Dis J. 2010;29:1105–1110. doi: 10.1097/INF.0b013e3181eb7388. - DOI - PubMed
    1. Elder E, Sinclair J. HCMV latency: what regulates the regulators? Med Microbiol Immunol. 2019;208:431–438. doi: 10.1007/s00430-019-00581-1. - DOI - PMC - PubMed
    1. Dell’Oste V, Biolatti M, Galitska G, Griffante G, Gugliesi F, Pasquero S, Zingoni A, Cerboni C, De Andrea M. Tuning the orchestra: HCMV vs. Innate immunity. Front Microbiol. 2020;11:1–20. doi: 10.3389/fmicb.2020.00661. - DOI - PMC - PubMed
    1. Parker EL, Silverstein RB, Verma S, Mysorekar IU. Viral-immune cell interactions at the maternal-fetal interface in human pregnancy. Front Immunol. 2020;11:1–16. doi: 10.3389/fimmu.2020.522047. - DOI - PMC - PubMed